Increased prevalence of antibrain antibodies in the sera from schizophrenic patients.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Schizophrenia Research

• Publication date

  1994-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0920-9964(94)90004-3PMID 7893617
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chlorpromazine-induced antinuclear factors.

  2009cited by this paper
• T-lymphocyte subpopulations in schizophrenic patients

  2005cited by this paper
• Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders

  2004cited by this paper
• Antibodies to brain tissue in sera of schizophrenic patients

  1993cited by this paper
• Antibrain antibodies in alcoholic patients.

  1993cited by this paper
• Antibodies against serotonin and gangliosides in schizophrenia and major depressive disorder

  1992cited by this paper
• The prevalence of autoantibodies among right and left handed schizophrenic patients and control subjects.

  1992cited by this paper
• Elevated IgG anti-histone antibodies in a subgroup of medicated schizophrenic patients.

  1992cited by this paper
• Antibodies to the human 60 kDa heat-shock protein in patients with schizophrenia.

  1992cited by this paper
• Hippocampal neuron number in schizophrenia. A stereological study.

  1991cited by this paper
• Platelet autoantibodies in dementia and schizophrenia. Possible implication for mental disorders.

  1991cited by this paper
• Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon.

  1991cited by this paper
• Cold agglutinin autoantibodies in psychiatric patients: their relation to diagnosis and pharmacological treatment.

  1991cited by this paper
• Autoantikörper bei Schizophrenie

  1991cited by this paper
• Antibodies to brain tissue in sera of patients with chronic progressive multiple sclerosis.

  1991cited by this paper
• Counterpoint: a sensory gating--hippocampal model of schizophrenia.

  1991cited by this paper
• Neuropsychological probes of fronto-limbic system dysfunction in schizophrenia. Olfactory identification and Wisconsin Card Sorting performance.

  1991cited by this paper
• Decreased hippocampal expression of a glutamate receptor gene in schizophrenia.

  1991cited by this paper
• Hippocampal injury and chronic schizophrenia.

  1991cited by this paper
• Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia.

  1991cited by this paper
• Platelet Autoantibodies in Dementia and Schizophrenia

  1991cited by this paper
• Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic.

  1991cited by this paper
• Autoantibodies in sera of schizophrenic patients

  1991cited by this paper
• Correlation of Negative Symptoms in Schizophrenia with Frontal Lobe Parameters on Magnetic Resonance Imaging

  1991cited by this paper
• Anticerebral antibodies in functional psychoses.

  1991cited by this paper
• Astrocytosis in the molecular layer of the dentate gyrus: a study in Alzheimer's disease and schizophrenia.

  1990cited by this paper
• Autoantibodies to brain lipids in schizophrenia.

  1990cited by this paper
• Increased forskolin binding in the left parahippocampal gyrus and CA1 region in post mortem schizophrenic brain determined by quantitative autoradiography.

  1990cited by this paper
• Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function.

  1990cited by this paper
• Brain magnetic resonance imaging: approaches for investigating schizophrenia.

  1990cited by this paper
• The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia.

  1990cited by this paper
• Notes from the graveyard: neuropathology and schizophrenia *

  1990cited by this paper
• Factors related to the presence of autoantibodies in patients with chronic mental disorders.

  1990cited by this paper
• Autoantibodies against brain septal region antigens specific to unmedicated schizophrenia?

  1990cited by this paper
• Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia.

  1990cited by this paper
• Midsagittal cortical pathomorphology of schizophrenia: a magnetic resonance imaging study.

  1989cited by this paper
• Antiseptal brain antibody in IgG of schizophrenic patients.

  1989cited by this paper
• The La antigen shuttles between the nucleus and the cytoplasm in CV-1 cells

  1989cited by this paper
• Antibody reactivity to brain membrane proteins in serum from schizophrenic patients.

  1989cited by this paper
• B cell and autoantibody repertoire in a pair of monozygotic twins discordant for myasthenia gravis.

  1989cited by this paper
• Influenza viruses induce autoantibodies to a brain-specific 37-kDa protein in rabbit.

  1989cited by this paper
• Laboratory investigations in clinical immunology: methods, pitfalls, and clinical indications. A second IUIS/WHO report.

  1988cited by this paper
• Schizophrenia and multiple sclerosis.

  1988cited by this paper
• Anti-histone antibodies in schizophrenia and affective disorders.

  1988cited by this paper
• Limbic pathology in schizophrenia: the entorhinal region--a morphometric study.

  1988cited by this paper
• Laboratory investigations in clinical immunology: methods, pitfalls and clinical indications. A second IUIS/WHO report.

  1988cited by this paper
• Clinical and Laboratory Evidence of Autoimmunity in Acute Schizophrenia

  1987cited by this paper
• A neuroimmunological challenge: schizophrenia as an autoimmune disease.

  1987cited by this paper
• Cytotoxic anti-lymphocyte antibody in schizophrenics

  1987cited by this paper
• Antibody to discrete areas of the brain in normal individuals and patients with schizophrenia.

  1987cited by this paper
• Is schizophrenia a viral or immunologic disorder?

  1986cited by this paper
• Myelin basic protein antibodies in catatonic schizophrenia.

  1986cited by this paper
• Are there antibodies against brain in sera from schizophrenic patients? Review and prospectus.

  1985cited by this paper
• Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage.

  1985cited by this paper
• Basal Ganglia and Limbic System Pathology in Schizophrenia: A Morphometric Study of Brain Volume and Shrinkage

  1985cited by this paper
• Sigma receptors and autoimmune mechanisms in schizophrenia: preliminary findings and hypotheses.

  1984cited by this paper
• Blood Lymphocytes in Schizophrenia — Immunological and Virological Aspects

  1983cited by this paper
• Antithymic antibodies in schizophrenic sera.

  1982cited by this paper
• Failure to detect immunologic stigmata in schizophrenia.

  1982cited by this paper
• Abnormal immune regulation in schizophrenic patients.

  1982cited by this paper
• Autoimmune model of schizophrenia with special reference to antibrain antibodies.

  1981cited by this paper
• Immunologic studies in schizophrenic and control subjects.

  1980cited by this paper
• Immunologic and coagulation disorders in chlorpromazine-treated patients.

  1979cited by this paper
• Aspects of humoral and cellular immunity in schizophrenia.

  1978cited by this paper
• Tissue-binding factor in schizophrenic sera: a clinical and genetic study.

  1977cited by this paper
• A Tissue-Binding Factor in the Serum of Schizophrenic Patients

  1977cited by this paper
• Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment.

  1975cited by this paper
• Demonstration of nuclear and cytoplasmic fluorescence in brain tissues of schizophrenic and nonschizophrenic patients.

  1974cited by this paper
• Antibodies to thymocytes in sera of patients with schizophrenia.

  1974cited by this paper
• Demonstration of nuclear and cytoplasmic fluorescence in brain tissues of schizophrenic and nonschizophrenic patients.

  1974cited by this paper
• Schizophrenia and autoimmune serological reactions.

  1973cited by this paper
• Antinuclear factor in psychiatric patients.

  1973cited by this paper
• Antinuclear Factor in Psychiatric Disorders

  1972cited by this paper
• Antinuclear factor in psychiatric disorders.

  1972cited by this paper
• Schizophrenia, an immunologic disorder?

  1970cited by this paper
• Absence of brain antibodies in patients with schizophrenia.

  1968cited by this paper
• Schizophrenia as an Immunologic Disorder: I. Demonstration of Antibrain Globulins by Fluorescent Antibody Techniques

  1967cited by this paper
• Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques.

  1967cited by this paper
• Investigation of Precipitins to Human Brain in Sera of Psychotic Patients

  1965cited by this paper
• Schizophrenia: Some New Aetiological Considerations

  1964cited by this paper

• Impact of second-generation antipsychotics monotherapy or combined therapy in cytokine, lymphocyte subtype, and thyroid antibodies for schizophrenia: a retrospective study

  2024cites this paper
• Skewing of the antibody repertoire in cerebrospinal fluid B cells from healthy controls and patients with schizophrenia

  2022cites this paper
• Contribution from MHC-Mediated Risk in Schizophrenia Can Reflect a More Ethnic-Specific Genetic and Comorbid Background

  2022cites this paper
• Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment

  2021cites this paper
• Role of a PTP1B Pathway in the Neuropsychiatric Expression of a Mouse Maternal Immune Activation Model

  2019cites this paper
• Activation of IL-8 and its participation in cancer in schizophrenia patients: new evidence for the autoimmune hypothesis of schizophrenia

  2018cites this paper
• The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia.

  2018cites this paper
• بررسی مقایسهای سطح آنتیبادی IgE توتال سرمی در بیماران مبتلا به اسکیزوفرنیا و اختلال افسردگی اساسی

  2017cites this paper
• Generating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction data

  2017cites this paper
• The Role of the Immune System in Autism Spectrum Disorder

  2017cites this paper
• A COMPARATIVE EVALUATION OF TOTAL SERUM LEVEL OF IGE ANTIBODY IN THE PATIENTS WITH SCHIZOPHRENIA AND MAJOR DEPRESSIVE DISORDER

  2017cites this paper
• Anti-phospholipid syndrome associated with schizophrenia description of five patients and review of the literature

  2017cites this paper
• Neuropil pruning in Early-Course Schizophrenia: Immunological, Clinical, and Neurocognitive Correlates.

  2016cites this paper
• Elevated Serum Interleukin-23 and Interleukin-6 Levels in Schizophrenic Patients Compared to Those in Healthy Controls

  2016cites this paper
• [Anti-NR1 antibodies in anti-N-methyl-D-aspartate receptor encephalitis and schizophrenia].

  2015cites this paper
• Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: an integrated DTI study.

  2015cites this paper
• Role of T helper lymphokines in the immune-inflammatory pathophysiology of schizophrenia: Systematic review and meta-analysis

  2015cites this paper
• Epilepsy-related psychosis: a role for autoimmunity?

  2014cites this paper
• Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis.

  2014cites this paper
• Anticorps anti-récepteur NMDA dans les premiers épisodes psychotiques

  2014cites this paper
• Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.

  2014influential citation
• HLA associations in schizophrenia: Are we re‐discovering the wheel?

  2014influential citation
• The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia.

  2013cites this paper
• Neuropsychiatric Autoimmune Encephalitis without VGKC-Complex, NMDAR, and GAD Autoantibodies: Case Report and Literature Review

  2013cites this paper
• Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.

  2013cites this paper
• Anti-brain autoantibodies in the serum of schizophrenic patients: a case-control study.

  2013cites this paper
• Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis‡

  2013cites this paper
• ZNAĈAJ ODREDJIVANJA INTERLEUKINA-6 I FAKTORA NEKROZE TUMORA KOD OBOLELIH OD SHIZOFRENIJE

  2013cites this paper
• Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?

  2012cites this paper
• Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology.

  2012cites this paper
• Schizophrenia is a TH2 dominant autoimmune disease possibly against acetylcholine receptors of CNS

  2012cites this paper
• Anti-Purkinje Cell and Natural Autoantibodies in a Group of Psychiatric Patients. Evidences for a Correlation with the Psychopathological Status

  2012cites this paper
• Psychiatry, Psychoimmunology, and Viruses

  2012cites this paper
• Avaliação dos níveis séricos das proteínas C3 e C4 em pacientes esquizofrênicos, bipolares controles saudáveis

  2011cites this paper
• Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia.

  2011cites this paper
• Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

  2010cites this paper
• Assessment of Therapy-Resistant Schizophrenia

  2010cites this paper
• Blind Verification of Elevated Platelet Autoantibodies in Serum of Schizophrenic Patients – Part II: Adult Subjects

  2009cites this paper
• Blind Verification of Elevated Platelet Autoantibodies in Serum of Schizophrenic Patients – Part I: Young Subjects

  2009cites this paper
• Elevated anticardiolipin antibodies in schizophrenic patients before and during neuroleptic medication.

  2009cites this paper
• Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis

  2009cites this paper
• Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics

  2008cites this paper
• The biochemical womb of schizophrenia: A review

  2008cites this paper
• A multi-etiology model of systemic degeneration in schizophrenia.

  2008cites this paper
• The Case for Autoimmunity in the Etiology of Schizophrenia

  2008cites this paper
• Schizophrenia and Immune Responses

  2008cites this paper
• Decreased T cellular immune response in schizophrenic patients.

  2007cites this paper
• Viral Infections as Etiological Factors of Schizophrenia

  2007cites this paper
• ESTUDIO DE LA FUNCIÓN INMUNITARIA EN PACIENTES ESQUIZOFRÉNICOS Y BIPOLARES TIPO I

  2007cites this paper
• Increased complement classical and mannan-binding lectin pathway activities in schizophrenia.

  2006cites this paper
• Autoantibodies associated with psychiatric disorders.

  2006cites this paper
• Bipolar Disorder: not only in the Brain - immunological aspects

  2006cites this paper
• Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization

  2006cites this paper
• Regulation of m1 muscarinic receptors and nNOS mRNA levels by autoantibodies from schizophrenic patients.

  2006cites this paper
• Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusing on MIF and CD14 gene polymorphisms.

  2006cites this paper
• ICAM G241A Polymorphism and Soluble ICAM-1 Serum Levels: Evidence for an Active Immune Process in Schizophrenia

  2005cites this paper
• Study of HLA-Linked Genes in Paranoid Schizophrenia in an Indian Bengalee Population

  2005cites this paper
• Haloperidol treatments increased macrophage activity in male and female rats: influence of corticosterone and prolactin serum levels.

  2005cites this paper
• Cortisol and Cytokines in Chronic and Treatment-Resistant Patients with Schizophrenia: Association with Psychopathology and Response to Antipsychotics

  2005cites this paper
• Immune dysregulation and self‐reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis?

  2005cites this paper
• Some biological correlates of drug resistance in schizophrenia: A multidimensional approach

  2005cites this paper
• Increased serum interleukin-1β and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication

  2005cites this paper
• Leukocyte Elastase and Autoantibodies to Nerve Growth Factor in the Acute Phase of Schizophrenia and their Relationship to Symptomatology

  2004cites this paper
• Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients' sera

  2004cites this paper
• Microarray- und immungenetische Untersuchungen bei Schizophrenie

  2004cites this paper
• A high prevalence of organ-specific autoimmunity in patients with bipolar disorder.

  2004cites this paper
• Studies characterizing 60 kda autoantibodies in subjects with schizophrenia.

  2003cites this paper
• Platelet-Associated Antibodies Mediate Protective Autoimmune Response in Schizophrenia

  2003cites this paper
• Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders.

  2003cites this paper
• Psycho-immunologie

  2002cites this paper
• Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.

  2002cites this paper
• Antibodies Against Cerebral M1 Cholinergic Muscarinic Receptor from Schizophrenic Patients: Molecular Interaction1

  2002cites this paper
• Immunity and schizophrenia: autoimmunity, cytokines, and immune responses.

  2002cites this paper
• Patients: Molecular Interaction Muscarinic Receptor from Schizophrenic Cholinergic 1 Antibodies Against Cerebral M

  2002cites this paper
• T-helper-1 and T-helper-2 responses in psychiatric disorders.

  2001cites this paper
• Review of immunological and immunopathological findings in schizophrenia.

  2001cites this paper
• Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms

  2001cites this paper
• Elevated Cellular Immune Response to Human Heat-Shock Protein-60 in Schizophrenic Patients

  1999cites this paper
• Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes.

  1999cites this paper
• Elevation of CD5+ B lymphocytes in schizophrenia.

  1999cites this paper
• Autoimmunity Against Platelets in Schizophrenia

  1999cites this paper
• On the myth of antibrain antibodies in schizophrenia — a critical overview

  1999cites this paper
• Serum levels of soluble IL-2 receptor α, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration

  1999cites this paper
• Antibrain antibodies in mental disorder: no evidence for antibodies against synaptic membranes

  1998cites this paper
• Effects of Clozapine on In Vitro Immune Parameters: A Longitudinal Study in Clozapine-Treated Schizophrenic Patients

  1998cites this paper
• [Bulimia and autoimmunity].

  1998cites this paper
• Immunologie et psychiatrie

  1998cites this paper
• Chronic Schizophrenia and Alzheimer´s Disease from the Viewpoint of a Neuroimmunologist

  1997cites this paper
• Immunological Factors in the Sera of Patients with Acute and Chronic Schizophrenia

  1997cites this paper
• Immunological alterations in three types of schizophrenia

  1997cites this paper
• Short and long-term immunosuppressive effects of clozapine and haloperidol.

  1997cites this paper
• Differences in the natural autoantibody patterns of patients with schizophrenia and normal individuals.

  1996cites this paper
• Hirnantikörper in den Seren von eineiigen Zwillingen mit Diskordanz für eine Schizophrenie

  1996cites this paper
• Altered T-Cell Function in Schizophrenia: A Cellular Model to Investigate Molecular Disease Mechanisms

  1996cites this paper